✦ LIBER ✦

Determination of plasma erythropoietin levels. An early marker of tumor activity

✍ Scribed by Athanasius Anagnostou; Manjeet S. Chawlamd; Linda Pololi; Walter Fried

Publisher: John Wiley and Sons
Year: 1979
Tongue: English
Weight: 279 KB
Volume: 44
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197909)44:3<1014::aid-cncr2820440332>3.0.co;2-u

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activities of erythropoietin on tumors:

Activities of erythropoietin on tumors: An immunological perspective

✍ Pietro Ghezzi; Manuela Mengozzi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

## Abstract There is a growing interest in the non‐erythropoietic, tissue‐protective and restorative actions of erythropoietin (EPO). While studies in this field have indicated that EPO can ameliorate chemotherapy‐induced peripheral neuropathy and cardiotoxicity, the issue whether EPO can positivel

Application of cancer procoagulant as an

Application of cancer procoagulant as an early detection tumor marker

✍ Diane L. Kozwich; Leslie C. Kramer; Wojciech P. Mielicki; Sophia S. Fotopoulos; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 889 KB

Elevation of serum lactic dehydrogenase

Elevation of serum lactic dehydrogenase levels as an early marker of occult malignant lymphoma

✍ Z. Rotenberg; I. Weinberger; Y. Fuchs; A. Erdberg; E. Davidson; J. Agmon 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB 👁 2 views

Plasma level of soluble Fas is an indepe

Plasma level of soluble Fas is an independent marker of cardiovascular disease in ESRD patients

✍ Meier, Pascal; Blanc, Edouard 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 269 KB

Validation of an immunoradiometric assay

Validation of an immunoradiometric assay to measure plasma levels of active renin

✍ Lynne K. Wathen; Kenneth W. Nuorala; Michael W. Wathen 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 747 KB

An immunoradiometric assay (IRMA) for active renin in human plasma was analytically and clinically validated. Analytical validation established 1) precision, 2) recovery, 3) linearity, 4) cross-reactivity, 5) sample stability, and 6) the validity and specificity of the '251-labeled anti-renin monocl

Serum tumor marker decline is an early p

Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy

✍ Barbara A. Murphy; Robert J. Motzer; Madhu Mazumdar; Vaia Vlamis; Jerome Nisselb 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 655 KB

Background. Serum tumor marker regression (alpha-fetoprotein [AFP] and human chorionic gonadotrophin (hCG]) was studied in patients treated with ifosfamide-based chemotherapy for cisplatin-resistant germ cell tumors (GCT) to investigate the role of marker regression as a predictor of treatment outco